Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

5.09
+0.17003.46%
Post-market: 5.110.0200+0.39%19:04 EDT
Volume:1.69M
Turnover:8.58M
Market Cap:469.18M
PE:-4.55
High:5.17
Open:4.93
Low:4.93
Close:4.92
Loading ...

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

GlobeNewswire
·
23 Jan

Leerink Partners Sticks to Their Hold Rating for Myriad Genetics (MYGN)

TIPRANKS
·
22 Jan

Myriad Genetics announces hereditary cancer risk assessment study published

TIPRANKS
·
21 Jan

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

GlobeNewswire
·
21 Jan

Myriad Genetics Price Target Maintained With a $20.00/Share by Stephens & Co.

Dow Jones
·
16 Jan

Myriad Genetics: Sell Rating Maintained Amid Mixed Financial Outlook and Limited Catalysts

TIPRANKS
·
16 Jan

TD Cowen Sticks to Its Hold Rating for Myriad Genetics (MYGN)

TIPRANKS
·
15 Jan

BUZZ-Myriad Genetics falls after preliminary Q4 revenue misses estimates

Reuters
·
15 Jan

Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance

MT Newswires Live
·
15 Jan

Myriad Genetics Inc Outlook FY25 REV $840 Mln - $860 Mln

THOMSON REUTERS
·
15 Jan

Myriad Genetics Inc - Q4 2024 Revenues Expected Between $209 Million and $211 Million

THOMSON REUTERS
·
15 Jan

Myriad Genetics Inc Qtrly Adj Diluted Earnings per Share (to Be Between $0.03 and $0.04

THOMSON REUTERS
·
15 Jan

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

GlobeNewswire
·
15 Jan

MYGN Stock Gains Following Collaboration With Hannah Storm

Zacks
·
10 Jan

Myriad Genetics Signs Agreement With Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

THOMSON REUTERS
·
10 Jan

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

GlobeNewswire
·
10 Jan

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
08 Jan

Myriad Genetics Forms 5-Year Alliance With MD Anderson to Evaluate Molecular Residual Disease Assay

MT Newswires Live
·
07 Jan

BRIEF-Myriad Genetics Announces 5 Year Strategic Alliance With University Of Texas

Reuters
·
07 Jan

Myriad Genetics: Announces 5 Year Strategic Alliance With University of Texas

THOMSON REUTERS
·
07 Jan